The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for ...

European Medicines Agency approves Moderna's mRNA flu vaccine with strong efficacy in older adults. US FDA initially declines ...

By Mariam Sunny and Michael Erman Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a ...

In December 2025, Moderna submitted an application to the FDA to approve the first mRNA-based flu vaccine. Catherine Falls Commercial/Moment via Getty Images Ana Santos Rutschman, Villanova University ...

The FDA has agreed to review Moderna’s investigational flu vaccine for potential approval, about a week after telling the drugmaker it would not consider the application. On Feb. 10, the agency ...

(Bloomberg) -- Moderna Inc.’s shares fell in late trading after US regulators refused to review its novel mRNA flu vaccine, dealing a major blow to the company as it seeks more products beyond its ...

The U.S. Food and Drug Administration (FDA) has refused to consider Moderna’s application for a new flu vaccine, which utilizes Nobel Prize-winning mRNA technology, the company announced on Tuesday.

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.The news is the ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Ana Santos Rutschman, Villanova University (THE CONVERSATION) The Food and Drug ...

Moderna said today the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling drugmaker ...